Eli Lilly (LLY)
(Delayed Data from NYSE)
$806.06 USD
-0.08 (-0.01%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $804.12 -1.94 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$806.06 USD
-0.08 (-0.01%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $804.12 -1.94 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Zacks News
Illumina (ILMN) Beats Q1 Earnings Estimates, Withdraws View
by Zacks Equity Research
Illumina (ILMN) exhibits robust growth in the first quarter of 2020 fueled by strong performance of the sequencing consumable subsegment despite the coronavirus pandemic.
Hologic (HOLX) Beats Q2 Earnings Estimates, Withdraws View
by Zacks Equity Research
Hologic (HOLX) exhibits robust segmental growth in second-quarter fiscal 2020, fueled by strong performance by the Diagnostics segment amid the coronavirus pandemic.
Remdesivir Progresses on Coronavirus Trial: Pharma Upbeat
by Ritujay Ghosh
A large number of biotech companies have been working on developing drugs and vaccine for the novel coronavirus that has infected more than 3,100,000 and claimed 227,000 lives.
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
by Zacks Equity Research
United Therapeutics (UTHR) beats estimates for both earnings and sales in first quarter. It expects a reduction in new patient starts in the future quarters. Stock down.
Eli Lilly and Company, PVH, Alphabet, Starbucks and Ford Motor highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Eli Lilly and Company, PVH, Alphabet, Starbucks and Ford Motor highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Eli Lilly (LLY)
by Tracey Ryniec
Double digit earnings growth expected in 2020 and it pays a dividend too.
Top Stock Research Reports for Cisco, Abbott, NextEra & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Cisco (CSCO), Abbott Laboratories (ABT) and NextEra Energy (NEE).
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Merck (MRK) beats estimates for earnings as well as for sales in first-quarter 2019. The company lowers its sales and earnings guidance to include impact of COVID-19. Shares down.
Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS
by Kinjel Shah
Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.
Bayer (BAYRY) Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Bayer (BAYRY) beats earnings estimates for the first quarter of 2019.
Company News for Apr 24, 2020
by Zacks Equity Research
Companies In The News Are: LLY, SAVA, FLR, LYTS
Will Eli Lilly and Company Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Eli Lilly and Company
Pharma Stock Roundup: Q1 Earnings of LLY, Coronavirus Update from PFE, NVS, AZN
by Kinjel Shah
Eli Lilly (LLY) announces Q1 results. Pfizer (PFE) and Novartis (NVS) provide update on their studies/plans to make coronavirus treatments or vaccines.
Eli Lilly (LLY) Is Up 7.93% in One Week: What You Should Know
by Zacks Equity Research
Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Jobless Claims Still High but Coming Down, Plus More Q1 Results
by Mark Vickery
4.427 million new jobless claims were made in the past week, bringing the total of the past 5 weeks of new claims data to north of 26 million workers in the U.S.
Lilly (LLY) Q1 Earnings Beat, Coronavirus May Mar Profits
by Zacks Equity Research
Eli Lilly (LLY) beat estimates for both earnings and sales in the first quarter of 2020. However, the company warns that coronavirus-related uncertainty may hurt financial results in 2020 and beyond.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Eli Lilly (LLY) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Lilly (LLY) delivered earnings and revenue surprises of 12.90% and 6.32%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Exxon Mobil, Oracle, Eli Lilly and Coke
The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics
Sanofi (SNY) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Investor focus is likely to be on the impact of the coronavirus outbreak on Sanofi's (SNY) performance when it reports first-quarter results.
Is a Surprise Coming for Lilly (LLY) This Earnings Season?
by Zacks Equity Research
Lilly (LLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings?
by Zacks Equity Research
Investor focus is likely to be on the impact of the coronavirus outbreak on Lilly's (LLY) performance when it reports first-quarter results.
The Zacks Analyst Blog Highlights: Netflix, Silgan, Citrix Systems, Eli Lilly and FirstEnergy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, Silgan, Citrix Systems, Eli Lilly and FirstEnergy
Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results
by Nalak Das
Economic activities came almost to a standstill in March. However, one sector that witnessed heightening activities is health care.